The results revealed that 56% of BCOR-positive sarcomas, 50% of undifferentiated uterine sarcomas, and 33% of spindle cell/sclerosing rhabdomyosarcomas presented moderate-intensity staining ranging from 0 to 56% (7). The gene discussed is BCOR; the disease is uterine corpus sarcoma.